Adjunct to diet & exercise in adults w/ insufficiently controlled type 2 DM as monotherapy when metformin is inappropriate due to intolerance or CIs; in combination w/ other medicinal products for diabetes.
Initially 3 mg once daily for 1 mth. May be increased to maintenance dose: 7 mg once daily for at least 1 mth. Then further increased to 14 mg once daily to improve glycaemic control.
View Rybelsus overdosage for action to be taken in the event of an overdose.
Administration
Should be taken on an empty stomach: Swallow whole, do not chew/crush/split. Refrain from eating, drinking, or taking other oral medications for at least 30 min after intake.
Discontinue use if pancreatitis is suspected. Not to be used in patients w/ type 1 DM or for diabetic ketoacidosis. Not recommended in patients w/ CHF NYHA class IV. Increased risk of hypoglycaemia in combination w/ sulfonylurea or insulin. GI effects; history of pancreatitis; diabetic retinopathy; bariatric surgery. May affect ability to drive & use machines. Severe renal & hepatic impairment. Not recommended in ESRD. Women of childbearing potential should use effective contraception. Not to be used during pregnancy & lactation. Childn & adolescents <18 yr. Elderly ≥75 yr.
Sign Out
